686 related articles for article (PubMed ID: 17182565)
21. The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Toraya T; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
J Immunol; 2008 Sep; 181(6):3897-905. PubMed ID: 18768844
[TBL] [Abstract][Full Text] [Related]
22. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
Cheng G; Yu A; Dee MJ; Malek TR
J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
[TBL] [Abstract][Full Text] [Related]
23. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells.
Wuest TY; Willette-Brown J; Durum SK; Hurwitz AA
J Leukoc Biol; 2008 Oct; 84(4):973-80. PubMed ID: 18653463
[TBL] [Abstract][Full Text] [Related]
24. The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation.
Liu B; Salgado OC; Singh S; Hippen KL; Maynard JC; Burlingame AL; Ball LE; Blazar BR; Farrar MA; Hogquist KA; Ruan HB
Nat Commun; 2019 Jan; 10(1):354. PubMed ID: 30664665
[TBL] [Abstract][Full Text] [Related]
25. Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.
Shi H; Liu C; Tan H; Li Y; Nguyen TM; Dhungana Y; Guy C; Vogel P; Neale G; Rankin S; Feng Y; Peng J; Tao W; Chi H
Immunity; 2018 Nov; 49(5):899-914.e6. PubMed ID: 30413360
[TBL] [Abstract][Full Text] [Related]
26. Requirement for POH1 in differentiation and maintenance of regulatory T cells.
Liu Y; Zhang L; Wang B; Yang Z; Xu G; Ma A; Tang M; Jing T; Wu L; Xu X; Liu Y
Cell Death Differ; 2019 Mar; 26(4):751-762. PubMed ID: 30038387
[TBL] [Abstract][Full Text] [Related]
27. MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function.
Xiang Y; Wang J; Li JP; Guo W; Huang F; Zhang HM; Li HH; Dai ZT; Zhang ZJ; Li H; Bao LY; Gu CJ; Chen K; Zhang TC; Liao XH
Cell Commun Signal; 2020 Jul; 18(1):107. PubMed ID: 32646440
[TBL] [Abstract][Full Text] [Related]
28. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
[TBL] [Abstract][Full Text] [Related]
29. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17.
Wang W; Edington HD; Rao UN; Jukic DM; Radfar A; Wang H; Kirkwood JM
Clin Cancer Res; 2008 Dec; 14(24):8314-20. PubMed ID: 19088050
[TBL] [Abstract][Full Text] [Related]
30. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
[TBL] [Abstract][Full Text] [Related]
31. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa.
Yuan X; Dee MJ; Altman NH; Malek TR
J Immunol; 2015 Feb; 194(3):1334-46. PubMed ID: 25527788
[TBL] [Abstract][Full Text] [Related]
32. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
[TBL] [Abstract][Full Text] [Related]
33. c-REL and IκB
Schuster M; Plaza-Sirvent C; Matthies AM; Heise U; Jeron A; Bruder D; Visekruna A; Huehn J; Schmitz I
J Immunol; 2017 Aug; 199(3):920-930. PubMed ID: 28652399
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
[TBL] [Abstract][Full Text] [Related]
35. Decreased regulatory function of CD4
Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
[TBL] [Abstract][Full Text] [Related]
36. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance.
Dikiy S; Li J; Bai L; Jiang M; Janke L; Zong X; Hao X; Hoyos B; Wang ZM; Xu B; Fan Y; Rudensky AY; Feng Y
Immunity; 2021 May; 54(5):931-946.e11. PubMed ID: 33838102
[TBL] [Abstract][Full Text] [Related]
37. IL-2Rβ abundance differentially tunes IL-2 signaling dynamics in CD4
Smith GA; Taunton J; Weiss A
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259099
[TBL] [Abstract][Full Text] [Related]
38. Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway.
Chen J; Huang C; Zhu D; Chen L; Wang J; Sun X; Hu L; Duan Y
J Cell Biochem; 2018 Dec; 119(12):10176-10185. PubMed ID: 30129110
[TBL] [Abstract][Full Text] [Related]
39. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
40. IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes.
Apert C; Romagnoli P; van Meerwijk JPM
Protein Cell; 2018 Apr; 9(4):322-332. PubMed ID: 28540653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
